Literature DB >> 18020595

Ankylosing spondylitis: current approaches to treatment.

A Toivanen1, T Möttönen.   

Abstract

To date there is no definite cure for ankylosing spondylitis. However, modern treatment improves the quality of life and the final outcome for most patients. Patient education and physiotherapy form the basis of treatment. In pharmacotherapy, nonsteroidal anti-inflammatory drugs have a central role. Second-line drugs such as sulfasalazine, immunomodulating agents and other antirheumatic disease-modifying drugs should be applied if the disease is active. Corticosteroids are used mainly intra-articularly. The problem of osteoporosis in ankylosing spondylitis is gaining more interest, and efforts to prevent or treat it will increase. It is critical to make an early diagnosis of ankylosing spondylitis and in active cases start intensive therapy before irreversible damage takes place.

Entities:  

Year:  1998        PMID: 18020595     DOI: 10.2165/00063030-199810030-00003

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


  2 in total

Review 1.  Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.

Authors:  A Toivanen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.

Authors:  Nai-Guo Wang; Da-Chuan Wang; Bing-Yi Tan; Feng Wang; Ze-Nong Yuan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.